Summary
Latest filing:
George A. Kegler files SEC Form 4 reports at Enveric Biosciences, Inc. (ENVB). 3 SEC Form 4 filings on record going back to 2024, most recently on 3 June 2026.
Recent Transactions
3Every recent SEC Form 4 transaction George A. Kegler has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at George A. Kegler's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Andrew T. Kaplan - $134.38M of KLRA open-market activity in the last 12 months
- BAIN CAPITAL INVESTORS LLC - $134.38M of KLRA open-market activity in the last 12 months
- Fairmount Funds Management LLC - $133.53M of APGE open-market activity in the last 12 months
- Matthew Rabinowitz - $133.06M of NTRA open-market activity in the last 12 months
- Jason P. Rhodes - $124.92M of DYN open-market activity in the last 12 months
- Stephen M. Bloch - $118.66M of LQDA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is George A. Kegler?
George A. Kegler is a corporate insider of Enveric Biosciences, Inc. (ENVB). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did George A. Kegler last file a Form 4?
The most recent primary Form 4 on record is dated 3 June 2026, one of 3 filings going back to 2024.
Where can I see all of George A. Kegler's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow George A. Kegler and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
